Download presentation
Presentation is loading. Please wait.
Published byDennis Franklin Modified over 9 years ago
1
Genomics, Medicine, and Society American College of Radiology May 13, 2003 Francis S. Collins, M.D., Ph.D.
7
A SMALL SAMPLING OF COOL THINGS ABOUT THE GENOME Humans have fewer protein-coding genes than expected – less than 30,000 Only about 5% of human DNA seems to be under strong selective pressure – but 2/3 of this is of unknown function Male mutation rate is twice that of females
8
All of the original goals of the Human Genome Project have been accomplished What’s next?
10
Genomics to Biology Define the structure of human variation: the human haplotype map Sequence lots of additional genomes Develop new technologies for sequencing, genotyping, expression analysis, proteomics, and molecular imaging Identify all functional elements of the genome Identify all the proteins of the cell, and their interactions Develop a computational model of the cell
11
Genomics to Biology Define the structure of human variation: the human haplotype map Sequence lots of additional genomes Develop new technologies for sequencing, genotyping, expression analysis, proteomics, and molecular imaging Identify all functional elements of the genome Identify all the proteins of the cell, and their interactions Develop a computational model of the cell
12
Finding genes for Mendelian phenotypes has made tremendous progress over the last 10 years Finding genes for complex (polygenic) disorders and traits has moved much more slowly
14
Sequence from chromosome 7 GAAATAATTAATGTTTTCCTTCCTTCTCCTATTTTGTCCTTTACTTCAATTTATTTATTTATTATTAATATTATTATTTTTTGAG ACGGAGTTTCACTCTTGTTGCCAACCTGGAGTGCAGTGGCGTGATCTCAGCTCACTGCACACTCCGCTTTCC/TGGTTT CAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGTCACACACCACCACGCCCGGCTAATTTTTGTATT TTTAGTAGAGTTGGGGTTTCACCATGTTGGCCAGACTGGTCTCGAACTCCTGACCTTGTGATCCGCCAGCCTCTGCCT CCCAAAGAGCTGGGATTACAGGCGTGAGCCACCGCGCTCGGCCCTTTGCATCAATTTCTACAGCTTGTTTTCTTTGCCT GGACTTTACAAGTCTTACCTTGTTCTGCCTTCAGATATTTGTGTGGTCTCATTCTGGTGTGCCAGTAGCTAAAAATCCAT GATTTGCTCTCATCCCACTCCTGTTGTTCATCTCCTCTTATCTGGGGTCACA/CTATCTCTTCGTGATTGCATTCTGATCCC CAGTACTTAGCATGTGCGTAACAACTCTGCCTCTGCTTTCCCAGGCTGTTGATGGGGTGCTGTTCATGCCTCAGAAAAA TGCATTGTAAGTTAAATTATTAAAGATTTTAAATATAGGAAAAAAGTAAGCAAACATAAGGAACAAAAAGGAAAGAACAT GTATTCTAATCCATTATTTATTATACAATTAAGAAATTTGGAAACTTTAGATTACACTGCTTTTAGAGATGGAGATGTAGTA AGTCTTTTACTCTTTACAAAATACATGTGTTAGCAATTTTGGGAAGAATAGTAACTCACCCGAACAGTGTAATGTGAATAT GTCACTTACTAGAGGAAAGAAGGCACTTGAAAAACATCTCTAAACCGTATAAAAACAATTACATCATAATGATGAAAAC CCAAGGAATTTTTTTAGAAAACATTACCAGGGCTAATAACAAAGTAGAGCCACATGTCATTTATCTTCCCTTTGTGTCTG TGTGAGAATTCTAGAGTTATATTTGTACATAGCATGGAAAAATGAGAGGCTAGTTTATCAACTAGTTCATTTTTAAAAGTC TAACACATCCTAGGTATAGGTGAACTGTCCTCCTGCCAATGTATTGCACATTTGTGCCCAGATCCAGCATAGGGTATGTT TGCCATTTACAAACGTTTATGTCTTAAGAGAGGAAATATGAAGAGCAAAACAGTGCATGCTGGAGAGAGAAAGCTGAT ACAAATATAAATGAAACAATAATTGGAAAAATTGAGAAACTACTCATTTTCTAAATTACTCATGTATTTTCCTAGAATTTAA GTCTTTTAATTTTTGATAAATCCCAATGTGAGACAAGATAAGTATTAGTGATGGTATGAGTAATTAATATCTGTTATATAATA TTCATTTTCATAGTGGAAGAAATAAAATAAAGGTTGTGATGATTGTTGATTATTTTTTCTAGAGGGGTTGTCAGGGAAAG AAATTGCTTTTTTTCATTCTCTCTTTCCACTAAGAAAGTTCAACTATTAATTTAGGCACATACAATAATTACTCCATTCTAA AATGCCAAAAAGGTAATTTAAGAGACTTAAAACTGAAAAGTTTAAGATAGTCACACTGAACTATATTAAAAAATCCACAG GGTGGTTGGAACTAGGCCTTATATTAAAGAGGCTAAAAATTGCAATAAGACCACAGGCTTTAAATATGGCTTTAAACTGT GAAAGGTGAAACTAGAATGAATAAAATCCTATAAATTTAAATCAAAAGAAAGAAACAAACTA/GAAATTAAAGTTAATATA CAAGAATATGGTGGCCTGGATCTAGTGAACATATAGTAAAGATAAAACAGAATATTTCTGAAAAATCCTGGAAAATCTTT TGGGCTAACCTGAAAACAGTATATTTGAAACTATTTTTAAA Three SNPs are present
15
Whole Genome Association Approach to Common Disease and Pharmacogenomics Identify all 10 million common SNPs Collect 1000 cases and 1000 controls Genotype all DNAs for all SNPs
16
2000 DNAs x 10,000,000 SNPs = 20,000,000,000 genotypes
17
Sequence from chromosome 7 GAAATAATTAATGTTTTCCTTCCTTCTCCTATTTTGTCCTTTACTTCAATTTATTTATTTATTATTAATATTATTATTTTTTGAG ACGGAGTTTCACTCTTGTTGCCAACCTGGAGTGCAGTGGCGTGATCTCAGCTCACTGCACACTCCGCTTTCC/TGGTTT CAAGCGATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGTCACACACCACCACGCCCGGCTAATTTTTGTATT TTTAGTAGAGTTGGGGTTTCACCATGTTGGCCAGACTGGTCTCGAACTCCTGACCTTGTGATCCGCCAGCCTCTGCCT CCCAAAGAGCTGGGATTACAGGCGTGAGCCACCGCGCTCGGCCCTTTGCATCAATTTCTACAGCTTGTTTTCTTTGCCT GGACTTTACAAGTCTTACCTTGTTCTGCCTTCAGATATTTGTGTGGTCTCATTCTGGTGTGCCAGTAGCTAAAAATCCAT GATTTGCTCTCATCCCACTCCTGTTGTTCATCTCCTCTTATCTGGGGTCACA/CTATCTCTTCGTGATTGCATTCTGATCCC CAGTACTTAGCATGTGCGTAACAACTCTGCCTCTGCTTTCCCAGGCTGTTGATGGGGTGCTGTTCATGCCTCAGAAAAA TGCATTGTAAGTTAAATTATTAAAGATTTTAAATATAGGAAAAAAGTAAGCAAACATAAGGAACAAAAAGGAAAGAACAT GTATTCTAATCCATTATTTATTATACAATTAAGAAATTTGGAAACTTTAGATTACACTGCTTTTAGAGATGGAGATGTAGTA AGTCTTTTACTCTTTACAAAATACATGTGTTAGCAATTTTGGGAAGAATAGTAACTCACCCGAACAGTGTAATGTGAATAT GTCACTTACTAGAGGAAAGAAGGCACTTGAAAAACATCTCTAAACCGTATAAAAACAATTACATCATAATGATGAAAAC CCAAGGAATTTTTTTAGAAAACATTACCAGGGCTAATAACAAAGTAGAGCCACATGTCATTTATCTTCCCTTTGTGTCTG TGTGAGAATTCTAGAGTTATATTTGTACATAGCATGGAAAAATGAGAGGCTAGTTTATCAACTAGTTCATTTTTAAAAGTC TAACACATCCTAGGTATAGGTGAACTGTCCTCCTGCCAATGTATTGCACATTTGTGCCCAGATCCAGCATAGGGTATGTT TGCCATTTACAAACGTTTATGTCTTAAGAGAGGAAATATGAAGAGCAAAACAGTGCATGCTGGAGAGAGAAAGCTGAT ACAAATATAAATGAAACAATAATTGGAAAAATTGAGAAACTACTCATTTTCTAAATTACTCATGTATTTTCCTAGAATTTAA GTCTTTTAATTTTTGATAAATCCCAATGTGAGACAAGATAAGTATTAGTGATGGTATGAGTAATTAATATCTGTTATATAATA TTCATTTTCATAGTGGAAGAAATAAAATAAAGGTTGTGATGATTGTTGATTATTTTTTCTAGAGGGGTTGTCAGGGAAAG AAATTGCTTTTTTTCATTCTCTCTTTCCACTAAGAAAGTTCAACTATTAATTTAGGCACATACAATAATTACTCCATTCTAA AATGCCAAAAAGGTAATTTAAGAGACTTAAAACTGAAAAGTTTAAGATAGTCACACTGAACTATATTAAAAAATCCACAG GGTGGTTGGAACTAGGCCTTATATTAAAGAGGCTAAAAATTGCAATAAGACCACAGGCTTTAAATATGGCTTTAAACTGT GAAAGGTGAAACTAGAATGAATAAAATCCTATAAATTTAAATCAAAAGAAAGAAACAAACTA/GAAATTAAAGTTAATATA CAAGAATATGGTGGCCTGGATCTAGTGAACATATAGTAAAGATAAAACAGAATATTTCTGAAAAATCCTGGAAAATCTTT TGGGCTAACCTGAAAACAGTATATTTGAAACTATTTTTAAA Are the SNPs correlated with their neighbors?
18
These three SNPs could theoretically occur in 8 different haplotypes …C…A…A… …C…A…G… …C…C…A… …C…C…G… …T…A…A… …T…A…G… …T…C…A… …T…C…G…
19
But in practice, only two are observed …C…A…A… …C…A…G… …C…C…A… …C…C…G… …T…A…A… …T…A…G… …T…C…A… …T…C…G…
20
~ 20,000 bp
22
A Haplotype Map of Human Variation Goal is to define all common haplotypes in the human genome Genome-wide association studies can then be done with 30 – 50 times less work Project is international (9 labs in 5 countries); was initiated in October 2002, using samples of African, Asian, and European origin
25
Genomics to Health Identify the genetic and environmental risk factors for all common disease Develop “sentinel systems” for early detection of disease and molecular taxonomy of illness Develop and deploy high-throughput robotic screening of small molecules for academic researchers Catalyze development of large human cohorts for genotype-phenotype correlations Elucidate the role that genomics can play in reducing health disparities Utilize genomics to improve health in the developing world
27
Genomics to Society Enhance genetic privacy and protection against genetic discrimination Encourage appropriate patenting and licensing practices to benefit the public Understand the relationship of genomics, race, and ethnicity, and bring this to bear usefully on the often contentious dialog about race Assess the ramifications of advances in understanding genetic factors that influence behavior Define boundaries of the appropriate application of genomics in the non-medical arena
28
What will be the impact of genomics on the practice of medicine?
29
I think there is a world market for maybe five computers. -- Thomas Watson Chairman of IBM, 1943
30
The concept is interesting and well- formed, but in order to earn better than a ‘C’, the idea must be feasible. -- Yale Professor evaluating Fred Smith’s student paper proposing the FedEx company
31
We don’t like their sound, and guitar music is on the way out. -- Decca Records, rejecting the Beatles, 1962
32
640K ought to be enough for anybody. -- Bill Gates, 1981
33
Most of the major contributing genes for diabetes, heart disease, cancer, mental illness, Alzheimer’s and Parkinson’s disease, asthma, etc. will be identified within the next 5 – 10 years.
38
Pharmacogenomics: Unlocking the Human Genome for Better Drug Therapy McLeod & Evans, Ann Rev Pharmacol Toxicol 41:101-21, 2001 All patients with same diagnosis Treat Remove No response Toxic response Responses without toxic side effects
40
Gleevec™ – Specifically Targets An Abnormal Protein, Blocking Its Ability To Cause Chronic Myeloid Leukemia Chromosome 9;22 translocation CML Bcr-Abl fusion protein Gleevec™ Bcr-Abl fusion protein Normal
41
2010 -- Predictive genetic tests available for a dozen conditions -- Interventions to reduce risk available for several of these -- Will reasonably effective legislative solutions to genetic discrimination be in place? BUT…. Mainstreaming of individualized preventive medicine -- Will access be inequitable? Will health disparities persist? -- Pharmacogenomics is standard of care for several drugs
42
2020 -- Gene-based designer drugs available for diabetes, Alzheimer’s… -- Gene therapy standard of care for several conditions BUT…. Genomic therapeutic revolution in full swing -- Intense debate underway on non-medical uses of genetics
44
www.genome.gov
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.